HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID


Forgot password

Remember my login

New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
MDD Perspectives
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals

Today's Issue of Medical Device Daily

Monday, February 8, 2016

Today's Headlines

Boston Scientific's CRM suffers in 4Q, but near-term improvement is expected

Competition from Medtronic plc hurt Boston Scientific Corp.'s cardiac rhythm management (CRM) business in the fourth quarter, analysts noted after Boston Scientific reported its earnings for the quarter.

Momma said there'd be days like this: Heartware pauses trial again

The mood was pretty somber going into Heartware's (Framingham, Mass.) breakout session during the 34th annual J.P. Morgan Healthcare conference. But why wouldn't it be? It's not everyday that a med-tech CEO has to discuss halting a European trial on one of its most promising technologies.

Inside the Beltway: User fee negotiations include a look at draft guidance issue

The negotiations for the next user fee schedule are well underway, and the FDA and device makers are addressing what some in industry see as sore spots. The FDA's proposals include development of a "myDevice" portal to allow for a more streamlined and interactive premarket review process, but the FDA has also said it would address the persistent draft status of guidances, vowing to take measures to ensure that guidances "are finalized in a timely manner."

MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement   |   Free Alerts

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com